17 September 2026
In a decisive move to reshape the landscape of chronic disease management across the European Union, Members of the European Parliament (MEPs) have officially adopted the Public Health Committee’s comprehensive report on cardiovascular diseases (CVDs). This legislative milestone represents a fundamental shift in how the EU approaches non-communicable diseases (NCDs), moving away from siloed treatments toward an integrated, holistic framework that recognizes the inextricable link between heart and lung health.
The adoption of this report is not merely a bureaucratic achievement; it is a direct response to the European Commission’s "Safe Hearts Plan," a strategic initiative designed to curb the prevalence of cardiovascular morbidity. By embracing this framework, the European Parliament has signaled its commitment to prioritizing early detection, robust prevention strategies, and multi-disciplinary care pathways that promise to improve the quality of life for millions of European citizens.
The Core Facts: A Paradigm Shift in NCD Policy
The primary objective of the newly adopted report is to institutionalize a "cross-disease" approach to public health. Historically, cardiovascular and respiratory conditions have been addressed through distinct clinical pathways. However, current medical consensus—supported by the European Respiratory Society (ERS)—posits that these systems are physiologically and pathologically intertwined.
Key Pillars of the Adopted Report:
- Prioritizing Prevention: Moving the focus from reactive treatment to proactive risk-factor management, including lifestyle interventions and environmental health policies.
- Integrated Early Detection: Mandating that health systems look beyond isolated symptoms to identify comorbidities, specifically recognizing that patients with cardiovascular issues are at a significantly higher risk of respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and obstructive sleep apnoea.
- The "Safe Hearts" Framework: Utilizing the European Commission’s Safe Hearts Plan to standardize care across all EU Member States, ensuring that geography does not dictate the quality of survival outcomes.
Chronology: From Strategy to Legislation
The road to this week’s vote was paved by years of advocacy and evolving clinical research.
- 2025 – The Emergence of the Safe Hearts Plan: The European Commission introduced the "Safe Hearts Plan," an ambitious directive aimed at reducing the burden of cardiovascular disease. The plan highlighted the need for a coordinated European effort to tackle the primary causes of premature death.
- Early 2026 – Committee Deliberations: The European Parliament’s Public Health Committee began drafting the response to the Commission’s proposal. During this period, key stakeholders, including the ERS and various patient advocacy groups, provided testimony emphasizing the "heart-lung" connection.
- Mid-2026 – Refinement and Integration: The report was amended to specifically include respiratory health, acknowledging that the comorbidities of heart disease are predominantly respiratory in nature.
- 17 September 2026 – Formal Adoption: Following a final plenary debate, the Parliament overwhelmingly voted to adopt the report, effectively mandating its implementation across the EU.
Supporting Data: Why the "Heart-Lung" Link Matters
The clinical evidence supporting the integration of respiratory assessment into cardiovascular care is compelling. Data provided by the ERS highlights that respiratory conditions, particularly COPD, are not just "co-occurring" illnesses; they share common risk factors, such as smoking, air pollution, and systemic inflammation.
The Impact of Comorbidity
Studies indicate that cardiovascular patients who also suffer from undiagnosed respiratory issues face a significantly higher mortality rate. By failing to screen for lung function during cardiac check-ups, healthcare systems miss a vital window for early intervention.
Standardized Screening Benefits
- Risk Stratification: Integrating respiratory function tests into routine cardiovascular screenings allows clinicians to build a more accurate profile of a patient’s total systemic health.
- Cost-Effectiveness: Early detection of COPD and sleep apnoea via existing cardiovascular pathways reduces the long-term economic burden on national health services by preventing emergency hospitalizations and reducing the need for intensive, late-stage medical care.
- Improved Patient Outcomes: A holistic approach ensures that treatment plans are comprehensive, addressing the root causes of systemic failure rather than managing individual symptoms in isolation.
Official Responses and Stakeholder Perspectives
The adoption of the report has been met with widespread approval from the medical and scientific communities, who view it as a triumph of evidence-based policy.
The European Respiratory Society (ERS) Stance
The ERS has been a vocal proponent of this integrated approach. In a formal statement following the vote, the Society emphasized that the inclusion of respiratory health in the broader NCD agenda is a long-overdue advancement. "The integration of targeted respiratory function assessment into cardiovascular health checks is not just a clinical suggestion; it is a necessity for modern medicine," stated a spokesperson for the Society.
The ERS has urged Member States to move beyond the legislative text and begin incorporating lung function testing into standardized health checks immediately, aligning with the ongoing "EU Screening Week" initiatives.
The European Commission’s Vision
For the European Commission, the vote validates the "Safe Hearts Plan" as a cornerstone of the European Health Union. By creating a framework that covers the entire health pathway—from initial prevention to rehabilitation—the Commission aims to reduce the "health inequality gap" between Western and Eastern European nations, where NCD mortality rates have historically varied significantly.
Implications: Implementing the Vision
While the adoption of the report is a historic achievement, the real challenge now lies in the implementation phase. Transforming policy into practice requires a multi-tiered effort involving the European institutions, national governments, the scientific community, and patient advocates.
The Path Forward
- Uniformity Across Member States: The most significant challenge will be ensuring that all 27 Member States adopt the same standards for cardiovascular and respiratory screenings. Differences in national health infrastructures may necessitate a tailored but aligned approach.
- Professional Training: Healthcare professionals—specifically primary care physicians and cardiologists—must receive training to effectively recognize and screen for respiratory comorbidities during routine cardiac exams.
- Public Awareness: Patients must be educated on the link between their heart and lung health. Awareness campaigns will be critical to encouraging citizens to demand comprehensive screenings that look at the body as an integrated system.
- Civil Society Engagement: The role of the European Lung Foundation and other patient-led organizations will be pivotal in holding governments accountable for the progress of the Safe Hearts Plan.
A Holistic Future
The vote on September 17, 2026, serves as a testament to the power of cross-disciplinary advocacy. By formally linking cardiovascular and respiratory health, the European Parliament has set a new global standard for how NCDs should be managed in the 21st century.
The success of this initiative will ultimately be measured not in parliamentary votes, but in the reduced rates of chronic illness and the increased life expectancy of the European population. As the EU moves to translate these policy directives into actionable measures, the focus remains clear: the health of the heart cannot be treated in isolation from the health of the lungs.
For those interested in the ongoing advocacy efforts or wishing to review the technical details of the ERS position, further documentation is available through the ERS and European Lung Foundation advocacy portal. This platform continues to serve as a vital resource for professionals and patients alike as they navigate this new, integrated chapter of European public health.
As we look toward the remainder of the decade, the integration of these two vital systems—cardiology and respirology—stands as a beacon for what is possible when science, policy, and public interest converge for the greater good of the European public.
